Pete joined LifeArc from Wellcome in Sep 2024 as Scientific Director in the Global Health team. He's an Immunologist with >20 years in the life sciences, >12 years bridging R&D across academia and Industry and 8 years strategy, public/private partnerships and portfolio investment in vaccines, biologics and drugs for infectious disease, with a focus on global access & affordability. Pete leads on strategy and delivery of LifeArc's AMR investment portfolio with a focus on monoclonal antibodies and passive immunisation.